EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:750158 - tralokinumab
| ChEBI ID | CHEBI:750158 |
| ChEBI Name | tralokinumab |
| Stars | |
| Last Modified | 29 June 2026 |
| Submitter | chembl-etl |
| Roles Classification |
|---|
| Applications: | dermatologic drug A drug used to treat or prevent skin disorders or for the routine care of skin. anti-asthmatic agent Any compound that has anti-asthmatic effects. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. anti-inflammatory agent Any compound that has anti-inflammatory effects. antifibrotic agent Any agent which acts to reduce fibrosis. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| tralokinumab (CHEBI:750158) has role anti-asthmatic agent (CHEBI:65023) |
| tralokinumab (CHEBI:750158) has role anti-inflammatory agent (CHEBI:67079) |
| tralokinumab (CHEBI:750158) has role antifibrotic agent (CHEBI:233423) |
| tralokinumab (CHEBI:750158) has role antineoplastic agent (CHEBI:35610) |
| tralokinumab (CHEBI:750158) has role dermatologic drug (CHEBI:50177) |
| tralokinumab (CHEBI:750158) is a organic molecular entity (CHEBI:50860) |
| Synonyms | Source |
|---|---|
| CAT-354 | ChEMBL |
| Tralokinumab | ChEMBL |
| Brand Names | Source |
|---|---|
| Adbry | ChEMBL |
| Adtralza | ChEMBL |